December 12, 2016 / 11:44 AM / 8 months ago

BRIEF-Idogen: Positive decision for Idogen's orphan designation application in Europe

Dec 12 (Reuters) - Idogen AB :

* The European Medicines Agency's Committee for Orphan Medicinal Products (COMP) has reached a positive decision regarding Idogen's application for orphan drug designation in Europe

* This means that the COMP has made the assessment that the application meets all the necessary criteria and they will therefore recommend that the European Commission grants Idogen a formal orphan drug designation

Source text: bit.ly/2hl4Ngg

Further company coverage:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below